1. Piller GJ: John Hughes Bennett: His life and identification of leukaemia. Proc R Coll Physicians Edinb, 1997.

2. Geary CG: The story of chronic myeloid leukaemia. Br J Haematol 110:2,2000.

3. Gunz FW, Henderson ED: Leukemia, 4th Ed. Grune & Stratton, New York, 1983.

4. Velpeau A: Sur la resorption du puseat sur l'altération du sang dans les maladies clinique de persection nenemant. Premier observation. Rev Med 2:216, 1827.

5. Piller G: The history of leukemia: A personal perspective. Blood Cells 19:521, 1993.

6. Donne A: De l'origine des globules du sang, de leur mode de formation, de leur fin. C R Acad Sci 14:366, 1842.

7. Craigie D: Case of disease of the spleen in which death took place consequent on the presence of purulent matter in the blood. Edinb Med Surg J 64:400, 1845.

Bennett JH: Case of hypertrophy of the spleen and liver in which death took place from suppuration of the blood. Edinb Med Surg J 64:413, 1845.

Virchow R: Weisses Blut und Milztumoren. Med Z 15:157, 1846. Fuller H: Particulars of a case in which enormous enlargement of the spleen and liver, together with dilatation of all vessels in the body were found coincident with a peculiarly altered condition of the blood. Lancet ii:43, 1846.

Wood GB: Trans Coll Physicians Philadelphia p. 265. 1850-52. Virchow R: Zur pathologischen Physiologie des Bluts: Die Bedeutung der milz- und Lymph-Drusen-Krankheiten fur die Blutmischung (Leukaemia). Virchows Arch 5:43, 1853. Neumann E: Ein Fall von Leukamie mit Erkrankung des Knochenmarkes. Arch Heilk 11:1, 1870.

Ebstein W: Ueber die acute Leukamie und Pseudoleukamie. Deut Arch Klin Med 44:343, 1889.

Ehrlich P: Parbenanalytische Untersuchungen zur Histologie und Klinik des Blutes. Hirschwald, Berlin, 1891.

Neumann E: Uber myelogene Leukamie. Berliner Klin Wochenschr 15:69, 1878.

Naegeli O: Uber rothes Knochenmark und Myeloblasten. Deut Med Wochenschr 18:287, 1900.

Turk W: Ein System der Lymphomatosen. Wien Klin Wochenschr 16:1073, 1903.

Bernard J: L'erythro-leucemie experimentale provoquée par les injections intramedullaires du goudron. Sang 8:28, 1934.

Storti E: Modifications morphologiques du sang et des organes hematopoietiques provoquées chez le rat blanc par injections intramedullaires de 1-2 benzopyrene. Sang 11:7, 1937.

Nowell PC, Hungerford DA: A minute chromosome in human granulocytic leukemia. Science 132:1497, 1960.

Fialkow PJ, Martin PJ, Najfeld V, Penfold GK, Jacobson RJ, Hansen

JA: Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood 58:159, 1981.

Stryckmans PA, Debusscher L, Collard E: Cell kinetics in chronic granulocytic leukaemia (CGL). Clin Haematol 6:21, 1977. Pederson B: Kinetics and cell function. In Shaw MT (ed.): Chronic Granulocytic Leukaemia, p. 93. Praeger, Eastbourne UK, 1982. De Klein A, van Kessel A, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR: A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300:765, 1982. Groffen J, Heisterkamp N, Stephenson JR, van Kessel A, de Klein A, Grosveld G, Bootsma D: c-sis is translocated from chromosome 22 to chromosome 9 in chronic myelocytic leukemia. J Exp Med 158:9, 1983.

Ben-Neriah Y, Daley GQ, Mes-Masson A-M, Witte ON, Baltimore D: The chronic myelogenous leukemia specific p210 protein is the product of the bcr/abl hybrid gene. Science 223:212, 1986. Lee M-S, Stass SA: Detection of chimeric bcr-abl mRNA and minimal residual disease by polymerase chain reaction. Hematology 13:241, 1991.

Osler W: Leukaemia. In The Principles and Practice of Medicine, 7th ed, p. 731. D. Appleton, New York, 1909.

Minot B, Isaacs R: Lymphatic leukemia: Age, incidence, duration and benefit derived from irradiation. Boston Med Surg J 191:1, 1924. Rai KR: Progress in chronic lymphocytic leukaemia: A historical perspective. Baillieres Clin Haematol 6:757, 1993. Galton DAG: The pathogenesis ofchronic lymphocytic leukaemia. Can Med Assoc J 94:1005, 1966.

Dameshek W: Chronic lymphocytic leukemia — an accumulative disease of immunologically incompetent lymphocytes. Blood 29:566, 1967.

34. Dormer P, Theml H, Lau B: Chronic lymphocytic leukaemia: A proliferative or accumulative disorder? Leuk Res 7:1, 1983.

35. Hockenberry DM, Oltvai ZN, Yin X-M, Milliman CC, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241, 1993f.

36. Zutter M, Hockenburg D, Silverman KA, Korsemeyer SJ: Immunolocalisation of the Bcl-2 protein within hematopoietic neoplasms. Blood 78:1062, 1991.

37. Aisenberg AC, Bloch KJ: Immunoglobulins on the surface of neo-plastic lymphocytes. N Engl J Med 287:272, 1972.

38. Preud'homme JL, Seligmann M: Surface bound immunoglobulins as a cell marker in human lymphoproliferative disease. Blood 40:777, 1972.

39. Giesler CH, Larsen JK, Hansen NE, Hansen MM, Christensen BE, Lund B, Nielson H, Plesner T, Thorling K, Andersen E, Andersen PK: Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 78:1795, 1991.

40. Freedman AS, Nadler LM: Immunological markers in B-cell chronic lymphocytic leukemia. In Cheson B (ed.): Chronic Lymphocytic Leukemia: Scientific Advances and Clinical Developments, p. 1. Marcel Dekker, New York, 1993.

41. Sweet DL, Golomb HM, Ultman JE: The clinical features of chronic lymphocytic leukaemia. Clin Haematol 6:185, 1977.

42. Lissauer H: Zwei Falle von Leukaemie. Berl Klin Wochenschr 2:403,

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment